Immunochemistry Reagents, Analysers And Test Kits: World Market 2016-2026

31 August 2016
Pharma

A new report by visiongain estimates that the  Immunochemistry market Report was worth $18.1bn in 2015. These forecasts and others appear in Immunochemistry Reagents, Analysers and Test Kits: World Market 2016-2026: Disease Specific Tests, Rapid Tests, Toxicology Tests, Endocrinology Tests, Therapeutic Drug Monitoring Tests, Anaemia/Vitamin Tests, Infectious Disease Tests, Autoimmune Disease Tests, Tumour Markers, Cardiac Markers, Allergic Blood Tests, Fertility Tests, Thyroid Tests, published in October 2016. Visiongain is a business intelligence company based in London, UK.
The reagents and test kits market is estimated to grow at a CAGR of 7.5% from 2015 to 2020, driven by the rapid tests submarket which is expected to grow at a CAGR of 9.5% from 2015 to 2020.
“The global immunochemistry industry is one of the largest sub- sectors of the global in vitro diagnostics (IVD) market, worth an estimated $18.1bn in 2015. Containing notable submarkets such as disease specific tests, endocrinology test, anaemia/vitamin tests and toxicology testing; this market has benefited from an improvement in both the hardware and software of the industry. Other factors such as the rise of the incidences of cancer, infectious diseases and cardiovascular diseases around the world will continue to fuel demand for better immunochemistry tests in the coming decade; ultimately leading to the emergence of India and China as alternatives to relatively expensive western production. Overall the global immunochemistry industry will progress steadily throughout the forecast period reaching $38.9bn in 2026.”
- Arvind Deol, pharmaceutical market analyst, visiongain, 2016
Visiongain’s new 160-page report provides revenue forecasts to 2026 for the global immunochemistry market, 11 leading submarkets and 9 leading national markets.
It forecasts the size of the immunochemistry market in the US, Japan, EU5: (Germany, France, Italy, Spain, UK), China, India, and the Rest of the World.
Along with revenue prediction for the overall world market, you see forecasts to 2026 for these submarkets:

• Immunochemistry reagents and tests kits
• Immunochemistry analysers

The study also forecasts immunochemistry reagents and tests kits subsectors

• Anaemia/Vitamin tests
• Disease specific tests
• Drugs of abuse/toxicology tests
• Therapeutic drug monitoring
• Endocrinology tests
• Rapid tests

This report profiles these leading companies:

• Roche
• Siemens Healthcare
• Abbott
• Danaher
• Ortho Clinical Diagnostics
• bioMérieux

Immunochemistry Reagents, Analysers and Test Kits: World Market 2016-2026: Disease Specific Tests, Rapid Tests, Toxicology Tests, Endocrinology Tests,Therapeutic Drug Monitoring Tests, Anaemia/Vitamin Tests, Infectious Disease Tests, Autoimmune Disease Tests, Tumour Markers, Cardiac Markers, Allergic Blood Tests, Fertility Tests, Thyroid Tests adds to visiongain’s range of analytical reports on industries and markets in healthcare.

Recent News

Visiongain Publishes Checkpoint Inhibitors for Treating Cancer Market Report 2021-2031

We predict strong revenue growth through to 2031. Our work identifies which organizations hold the greatest potential. Discover their capabilities, progress, and commercial prospects, helping you stay ahead.

29 July 2021

Read

Visiongain Publishes Direct-to-Patient Market Report 2021-2031

Over the last few years, Direct-to-Patient has gained widespread attention. DTP companies offer their customers, who are patients, in this case, all kinds of services.

21 July 2021

Read

Visiongain Publishes Drug Delivery Technologies Market Report 2021-2031

Rising geriatric population, increasing prevalence of chronic and infectious diseases, escalating investment in drug R&D by biopharmaceutical companies, rising demand for advanced drug delivery technologies for chronic treatment are some of the major factors that drive the growth of the global drug delivery technologies market.

20 July 2021

Read

Visiongain Publishes Pharma Contract Sales Market Report 2021-2031

Pharma services companies are widening their service offerings (either organically or inorganically through M&A) to become full-service providers, simplifying their customers’ operations and gaining the maximum share of their outsourcing budgets, driven by the willingness of pharma to reduce the number of outsourcers they use.

14 July 2021

Read

Kelloggs
3m
Thales
Shell
TEVA
Lockheed-Martin
Pfizer
Raytheon
Halliburton
Du-Pont
Honeywell
Daimler
BASF
Bayer
BP
BAE-Systems
Unilever